Loading clinical trials...
Loading clinical trials...
This trial is conducted in Africa, Europe and Middle East. This trial investigates the efficacy and safety of three dose levels of Norditropin® (growth hormone) as compared to placebo in the treatment...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novo Nordisk A/S
NCT06612762 · Bone Fractures
NCT07193524 · Tibia Fractures, Trauma (Including Fractures), and more
NCT06324084 · Osteoporosis, Bone Fracture, and more
NCT06249906 · Bone Lesion, Cartilage Degeneration, and more
NCT02477007 · Pain, Long-bone Fractures
Novo Nordisk Investigational Site
Kuopio
Novo Nordisk Investigational Site
Oulu
Novo Nordisk Investigational Site
Strasbourg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions